Direct Oral Anticoagulants: Probability of Recurrent Venous Thromboembolism and Bleeding Risk in an Obese Population

CS Pilkerton, M Adelman, E Crocetti… - Annals of … - journals.sagepub.com
Background: Direct-acting oral anticoagulants (DOACs) have become the preferred drugs
for managing venous thromboembolism (VTE). Despite their advantages over vitamin K …
被引用次数：1 相关文章

Direct Oral Anticoagulants: Probability of Recurrent Venous Thromboembolism and Bleeding Risk in an Obese Population.

CS Pilkerton, M Adelman, E Crocetti… - The Annals of …, 2023 - europepmc.org
Background Direct-acting oral anticoagulants (DOACs) have become the preferred drugs for
managing venous thromboembolism (VTE). Despite their advantages over vitamin K …

Direct Oral Anticoagulants: Probability of Recurrent Venous Thromboembolism and Bleeding Risk in an Obese Population

CS Pilkerton, M Adelman, E Crocetti… - The Annals of … - pubmed.ncbi.nlm.nih.gov
Background Direct-acting oral anticoagulants (DOACs) have become the preferred drugs for
managing venous thromboembolism (VTE). Despite their advantages over vitamin K …